Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

252.86 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments
Via FinancialNewsMedia
News headline image
Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript ↗
JAZZ earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Recap: Jazz Pharmaceuticals Q2 Earnings ↗
Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 5.12% over the past... 
Via Benzinga
News headline image
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates ↗
The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi... 
Via Benzinga
Where Jazz Pharmaceuticals Stands With Analysts ↗
Within the last quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ... 
Via Benzinga
News headline image
Jazz Pharmaceuticals's Earnings: A Preview ↗
Jazz Pharmaceuticals (NASDAQ:JAZZ) releases its next round of earnings this Tuesday, August 03. Get the latest predictions in Benzinga's essential guide to the company's Q2... 
Via Benzinga
News headline image
Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So. ↗
Cannabis operators and executives tell Benzinga that the movement of private and public companies may serve as a better indicator of regula... 
Via Benzinga
Topics Cannabis
News headline image
Is Jazz Pharmaceuticals Stock a Buy? ↗
Jazz Pharma is not the most popular drugmaker, but it is definitely worth a second look. 
Via The Motley Fool
News headline image
The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More ↗
Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021. Justice Thomas&nbs... 
Via Benzinga
Topics Cannabis
News headline image
Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June ↗
The Global Cannabis Stock Index fell for the fourth straight month, dropping 4.1% to 57.10. During the second quarter, the index was down... 
Via Benzinga
Topics Cannabis
News headline image
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... 
Via Benzinga
News headline image
Jazz Pharma's Rylaze Scores FDA Approval For Blood Cancer ↗
The FDA has approved Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the treatment of acute lymphoblastic... 
Via Benzinga
News headline image
Got $5,000? These 3 Stocks Are Ridiculously Cheap Buys ↗
They are great options whether you are investing for the short or long term. 
Via The Motley Fool
Topics Cannabis
News headline image
Finding Value In Mid-Cap Stocks ↗
Within the mid-cap space there is something for everyone. 
Via Talk Markets
News headline image
New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End ↗
The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or... 
Via Benzinga
News headline image
14 Biotech Stocks To Watch Over The Next 6 Months ↗
Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
Goldman Sachs lowered Casey's General Stores, Inc. (NASDAQ: 
Via Benzinga
News headline image
10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Friday ↗
Piper Sandler raised Adobe Inc. (NASDAQ: ADBE) price target from $570 to $600. Adobe shares rose 3.3% to $569.50 in pre-market trading. SVB Leerink boosted Jazz... 
Via Benzinga
News headline image
Jazz Pharmaceuticals Updates 2021 Guidance To Include GW Pharma Acquisition ↗
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has updated its full-year 2021 financial guidance to incorporate the GW Pharmaceuticals business, which the company... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
News headline image
The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (... 
Via Benzinga
News headline image
Cannabis investors Discuss Strategies For 2021 In The Context Of Consolidation And Interstate Commerce ↗
2021 seems to be the year of cannabis, as its prospects and apparent societal acceptance have dramatically changed since the industr... 
Via Benzinga
Topics Cannabis
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels
Via FinancialNewsMedia
Topics Cannabis Economy
News headline image
6 Mid-Cap Gems for Growth at a Reasonable Price ↗
A look at 6 attractively valued mid-cap stocks that are trading at valuations that are lower than their expected long-term growth rates. 
Via Talk Markets
Agentix Corp. (AGTX) Signs Deal With NHRI To License CBD-Based Compound To Treat Type 2 Diabetes; Adds Catalyst To Back Half Of 2021
Via AB Newswire
Topics Intellectual Property
News headline image
The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.